Sort by 
Ireland’s First Life Sciences Strategy: A Once-in-a-Generation Policy Opportunity
Ireland is developing its first National Life Sciences Strategy, due by end of June 2026. The strategy presents a once-in-a-generation opportunity to coordinate pharma, medtech, and digital health policy ahead of Ireland’s EU Council Presidency.
WuXi Biologics joins Life Sciences Industry Awards 2026 as Affiliate Partner
WuXi Biologics has joined the Life Sciences Industry Awards 2026 as Affiliate Partner, bringing global CRDMO expertise to the programme ahead of the awards gala on 28 May at the Crowne Plaza Hotel, Santry.
Jean Casey of Eli Lilly receives Legacy Award at the Women in Pharma Awards 2026
Jean Casey of Eli Lilly received the Legacy Award at the Women in Pharma Awards 2026, recognised for a career of nearly three decades spanning finance, commercial operations, and public affairs that has shaped Eli Lilly's standing in Ireland while contributing to industry advocacy, inclusion, and patient access at a national level. Her recognition underscores the breadth of impact that sustained, cross-functional leadership can have on Ireland's pharmaceutical sector, setting a compelling standard for the next generation of women building careers across the industry.
KM Biologics enters technology collaboration with Serum Institute of India for Japanese encephalitis vaccine
Japan-based KM Biologics has entered a technology collaboration with Serum Institute of India to develop and manufacture a Japanese encephalitis vaccine, targeting stable large-scale supply under India's national immunisation programme.
AstraZeneca reverses UK investment pause with £300m commitment across two sites
British pharmaceutical giant AstraZeneca has reversed its investment pause to commit £300 million across its Cambridge and Macclesfield sites in the UK, unfreezing a paused £200 million Cambridge expansion and committing £100 million to a Macclesfield laboratory.
Dr. Falk Pharma and Renexxion report positive Phase 2b results for naronapride in gastroparesis
German pharmaceutical company Dr. Falk Pharma and Irish clinical-stage biopharmaceutical firm Renexxion have announced positive Phase 2b trial results for naronapride in adults with gastroparesis, meeting the primary endpoint across two dose groups.
AstraZeneca opens new API manufacturing facility in Dublin with advanced automation and AI
AstraZeneca has officially opened a new active pharmaceutical ingredient manufacturing facility in Dublin, integrating advanced automation, artificial intelligence, and innovative technologies to support its global oncology portfolio and broader medicines pipeline.
Winners announced at the 2026 Women in Pharma Awards
The 2026 Women in Pharma Awards gala took place on 29 April at the Crowne Plaza Hotel, Santry, honouring outstanding women across Ireland's pharma and life sciences sector. Emma Kilgallon of West Pharmaceutical Services received the Overall Leader Award as the evening's top honour, with winners named across more than fifteen categories.
PCI Pharma Services commits over $1 billion to expand sterile fill-finish and drug-device capabilities
US-based global CDMO PCI Pharma Services has announced a series of major infrastructure investments exceeding $1 billion across its US and European operations, substantially expanding its sterile fill-finish and drug-device combination delivery capabilities.
Aptus Pharma doubles revenue and expands portfolio to 250 formulations in growth push
India-based BSE SME-listed Aptus Pharma Limited has doubled its revenue and expanded its product portfolio to over 250 formulations, as the pharmaceutical company accelerates multi-vertical expansion toward pan-India presence by 2030.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
